21-1356

LRB-1356/P2

TJD:cdc

2021 - 2022 LEGISLATURE

DOA:......Sherwin, BB0456 - Opioid and methamphetamine data system

For 2021-2023 Budget -- Not Ready For Introduction

An Act ...; relating to: the budget.

Analysis by the Legislative Reference Bureau

health and human services

Mental illness and developmental disabilities

Opioid and methamphetamine data system

This bill requires DOA to issue a request for proposals to establish and maintain an opioid and methamphetamine data system to collect, format, analyze, and disseminate information on opioid and methamphetamine use as specified in the bill. DOA must collaborate with and collect data from DHS, DOC, DOJ, DSPS, and DCF and any other applicable agencies for the opioid and methamphetamine data system. Under the bill, DOA administers the contract with a vendor to operate the opioid and methamphetamine data system, has access to the data contained in the opioid and methamphetamine data system, and works with the vendor to disseminate information and advanced analytics from the opioid and methamphetamine data system in as close to real time as possible. The opioid and methamphetamine data system must allow the state agencies that submit data to the opioid and methamphetamine data system access to the data in the opioid and methamphetamine data system as appropriate for the agency to fulfill its functions and as allowed by state and federal confidentiality laws. The bill requires DOA to submit a report to the governor and appropriate standing committees of the legislature summarizing the information from the opioid and methamphetamine data system and analyzing trends in that information across years of data collection.

For further information see the state fiscal estimate, which will be printed as an appendix to this bill.

The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:

Section 1 . Subchapter III of chapter 153 [precedes 153.85] of the statutes is created to read:

Chapter 153

Subchapter III

Opioid and
METHAMPHETAMINE data

153.85 Definition; opioid and methamphetamine data. In this subchapter, “vendor” means a person awarded the contract following a request for proposals described under s. 153.87.

153.87 Opioid and methamphetamine data system. (1) Subject to sub. (3), the department of administration shall issue a request for proposals to establish and maintain an opioid and methamphetamine data system to collect, format, analyze, and disseminate information on opioid and methamphetamine use, which shall include all of the following:

(a) Hospital discharge data from visits and stays related to opioid use or overdose.

(b) Hospital discharge data from visits and stays related to methamphetamine use or overdose.

(d) Records of hospitals diverting patients to other facilities to address methamphetamine use or overdose.

(e) Ambulance service run data related to opioid use or overdose.

(f) The number of opioid-related overdoses in the state, the number of individuals who overdose on opioids, and the opioids on which the individuals overdose.

(g) The number of methamphetamine-related overdoses in the state, the number of individuals who overdose on methamphetamines, and the forms of methamphetamines on which the individuals overdose.

(h) Death records related to opioid use or overdose.

(i) Death records related to methamphetamine use or overdose.

(j) The number of opioid treatment centers in the state, by the owner or operator of each opioid treatment center.

(k) The number of methamphetamine treatment centers in the state, by the owner or operator of each methamphetamine treatment center.

(L) The number of providers in this state that are allowed to prescribe a drug that is a combination of buprenorphine and naloxone, the patient capacity for those prescribers, the number of patients taking such a combination drug, and the number of patients who have discontinued such a combination drug due to successful completion of a treatment program.

(m) The number of methadone clinics in the state, the number of patients taking methadone, the number of patients who more than once have been on courses of methadone, the number of patients who have discontinued methadone use due to successful completion of a treatment program, and the number of patients who are receiving methadone treatment for each of the following durations:

1. Longer than 12 months.

2. Longer than 3 years.

3. Longer than 4 years.

4. Longer than 5 years.

5. Longer than 8 years.

6. Longer than 10 years.

(o) The amount of naloxone doses dispensed, the total number of naloxone doses administered, and the number of unique patients who have received doses of naloxone.

(p) The number of adults in the state who use opioids, the extent to which those adults use opioids, and the type of opioids used.

(q) The number of adults in the state who use methamphetamines, the extent to which those adults use methamphetamines, and the forms of methamphetamines used.

(r) The number of minors in the state who use opioids, the extent to which those minors use opioids, and the type of opioids used.

(s) The number of minors in the state who use methamphetamines, the extent to which those minors use methamphetamines, and the forms of methamphetamines used.

(t) The number of minors who enter the child protective services system due to opioid use by a parent or guardian, length of time those minors are in out-of-home care, and the type of reporter who notified child protective services of the needs of the minor.

(u) The number of persons who are incarcerated and who are receiving naltrexone for extended-release in injectable suspension, the number of persons who are on extended supervision or probation or on parole and who are receiving extended-release naltrexone, the total number of doses of extended-release naltrexone administered to persons who are incarcerated, on extended supervision or probation, or on parole in this state, and the length of time that persons who are incarcerated, on extended supervision or probation, or on parole are receiving extended-release naltrexone.

(v) The number of arrests and convictions related to methadone and the number related to a drug that is a combination of buprenorphine and naloxone.

(w) The number of arrests and convictions related to methamphetamines.

(2) The opioid and methamphetamine data system under sub. (1) shall identify, to the extent possible, for sub. (1) (a), (b), (c), (d), (e), (f), (g), (h), (i), (L), (m), (p), (q), (r), (s), and (u) the number of individuals who have each of the following forms of health care coverage:

(a) Public health care coverage under the Medical Assistance program.

(b) Public health care coverage under Medicare, a veteran or military health plan, or another public form of coverage other than Medical Assistance, including any self-insured governmental health plan.

(d) Self-coverage or uninsured.

(3) The department of administration shall collaborate with and collect data from the departments of health services, corrections, justice, safety and professional services, and children and families and any other applicable agencies for the opioid and methamphetamine data system under sub. (1).

(4) (a) The department of administration shall administer the contract with the vendor to operate the opioid and methamphetamine data system and shall have access to the data contained in the opioid and methamphetamine data system. The department of administration shall work with the vendor to disseminate information and advanced analytics from the opioid and methamphetamine data system in as close to real time as possible.

(b) The opioid and methamphetamine data system shall allow the state agencies that submit data to the opioid and methamphetamine data system access to the data in the opioid and methamphetamine data system as appropriate for the agency to fulfill its functions and as allowed by state and federal confidentiality laws.

153.89 Reports; opioid and methamphetamine data system. By January 1, 2023, and annually thereafter, the department of administration shall submit a report to the governor and, under s. 13.172 (3) to appropriate standing committees of the legislature., as determined by the speaker or president, summarizing the information from the opioid and methamphetamine data system under s. 153.87 (1) and analyzing trends in that information across years of data collection.

Section 9101. Nonstatutory provisions; Administration.

(1) Opioid and methamphetamine data system. From the appropriation under s. 20.505 (1) (a), the department of administration shall allocate $1,500,000 in fiscal year 2021-22 as one-time funding to implement the opioid and methamphetamine data system under subch. III of ch. 153.

(End)